The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term (=5 year) remission and survival after treatment with ciltacabtagene autoleucel (cilta-cel) in CARTITUDE-1 patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Peter Voorhees
Consulting or Advisory Role - Abbvie/Genentech; Ascentage Pharma; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Kite, a Gilead company; Pfizer; Regeneron; Sanofi
Research Funding - Abbvie (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Regeneron (Inst); TeneoBio (Inst)
 
Tom Martin
Consulting or Advisory Role - AstraZeneca; GlaxoSmithKline; Lilly; Pfizer
Research Funding - AMGEN (Inst); BMSi; Janssen Oncology (Inst); Sanofi (Inst)
 
Yi Lin
Consulting or Advisory Role - Adicet Bio (Inst); Bristol-Myers Squibb (Inst); Caribou Biosciences (Inst); Chimeric Therapeutics (Inst); Fosun Kite (Inst); Genentech (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Nektar (Inst); NexImmune (Inst); Pfizer (Inst); Regeneron (Inst); Sanofi (Inst); Tessera (Inst); Vineti (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)
 
Adam Cohen
Consulting or Advisory Role - Abbvie; Arcellx; Bristol Meyers Squibb; GlaxoSmithKline; Ichnos Sciences; ITeos Therapeutics; Janssen Oncology; Novartis; Pfizer; Roche/Genentech; Takeda
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to CAR T cells and biomarkers of Cytokine Release Syndrome
Travel, Accommodations, Expenses - Abbvie; Bristol-Myers Squibb; Ichnos Sciences; Janssen Oncology; Janssen Oncology
 
Noopur Raje
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Caribou Biosciences; Celgene; Immuneel Therapeutics; Janssen Oncology; Merck; Pfizer; Takeda
Research Funding - Bluebird Bio (Inst); Pfizer (Inst)
 
Myo Htut
Consulting or Advisory Role - Millennium
Research Funding - BMS (Inst); Judy and Bernard Briskin Center for Multiple Myeloma Research (Inst)
Travel, Accommodations, Expenses - Millennium
 
Abhinav Deol
Consulting or Advisory Role - Adicet Bio; Agios; Janssen; Juno/Celgene; Kite/Gilead; Novartis
 
Mounzer Agha
Stock and Other Ownership Interests - GenCart
 
Jesus Berdeja
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Galapagos NV; Genentech; Johnson & Johnson; Karyopharm Therapeutics; Kite, a Gilead Company; Kyowa Kirin; Pfizer; Regeneron; Roche; Sebia
Speakers' Bureau - Janssen
Research Funding - 2seventy bio; AstraZeneca; Bristol-Myers Squibb; C4 Therapeutics; Caribou Biosciences; CARsgen Therapeutics; Cartesian Therapeutics; Celularity; Genentech; GlaxoSmithKline; Gracell; Ichnos Sciences; Johnson & Johnson; Juno Therapeutics; K36 therapeutics; Karyopharm Therapeutics; Kite, a Gilead Company; Moderna Therapeutics; Pfizer; Regeneron; Roche; Sanofi; Takeda
 
Binod Dhakal
Honoraria - Celgene; GlaxoSmithKline; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Amgen; Arcellx; Genentech/Roche; GlaxoSmithKline; Janssen Oncology; Natera; Pfizer; Sanofi; Takeda
Speakers' Bureau - Janssen Oncology
Research Funding - Amgen (Inst); Arcellx (Inst); Bristol-Myers Squibb/Celgene (Inst); CARsgen Therapeutics (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Andrzej Jakubowiak
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Gracell; Janssen; Karyopharm Therapeutics; Sanofi
 
Samir Parekh
Employment - Mount Sinai Health System
Consulting or Advisory Role - Genentech/Roche; GRAIL; Poseida Theraputics; Regeneron
Research Funding - Caribou Biosciences; Celgene/BMS Corporation; GRAIL; imCORE; Poseida Theraputics
 
Hui Li
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Johnson & Johnson
 
Rocio Montes de Oca
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Huabin Sun
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Nikoletta Lendvai
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Deepu Madduri
Employment - Bitterroot Bio (I); Johnson & Johnson
Leadership - Bitterroot Bio (I); Johnson & Johnson
Stock and Other Ownership Interests - Bitterroot Bio (I); Johnson & Johnson
 
Mythili Koneru
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Nitin Patel
Employment - Legend Biotech
Stock and Other Ownership Interests - Legend Biotech
 
Sundar Jagannath
Consulting or Advisory Role - Bristol-Myers Squibb; Caribou Biosciences; Genmab; GlaxoSmithKline; Janssen; Legend Biotech; Poseida; Regeneron; Sanofi; Takeda
Travel, Accommodations, Expenses - Brystol-Myers Squibb; Internation Myeloma Society; Janssen Biotech; Poseida; Regeneron